The UK's TTP Group has revamped its Explorer range of microplate readers in the wake of the merger last month of the screening interests of two of its operating companies - TTP LabTech and Acumen Bioscience.
The Explorer range, originally developed by TTP LabTech and sold by Acumen, has been refocused around a single, fully upgradeable instrument that can meet the differing demands of users, according to the company. The device is a laser-scanning fluorescence microplate reader that enables the development and execution of cell-based high content screens.
"The changes have permitted a price reduction across the range, heralding a highly competitive entry price point for Explorer,", said the firm in a statement, noting that the instrument is in active use in major pharmaceutical and drug discovery companies throughout the world.
Dr Jas Sanghera, TTP LabTech's commercial director, said that the consolidation of the Explorer within its product range also offers existing and future customers an enhanced level of service and support as the firm has been able to expand its service and support team.
Since the merger, TTP LabTech has been responsible for both commercial and technical functions for the Explorer range, as well as the manufacture of the compound storage system, comPOUND, and the mosquito nanolitre pipetting station, both of which debuted at last year's Society of Biomolecular Screening annual meeting.
For further information on the Acumen Explorer range, contact TTP LabTech.